Abstract
Background
The objective of this study was to assess clinicopathological characteristics and outcomes of lupus nephritis adult patients in China.
Methods
Clinicopathological features, treatment strategies, responses and outcome of 681 adult patients with biopsy-proved lupus nephritis were retrospectively analyzed.
Results
Six hundred and eighty-one LN patients were included and followed up for 52.5 ± 14.1 months. Differences in age, disease duration, BP, proteinuria, serum albumin, creatinine, ANCA-positive ratio and SLEDAI scores were noticed between male and female patients, indicating severer disease in male patients. LN IV patients were much severer in systemic damage as well as immunological changes. During follow-up, 354 patients achieved CR, 107 patients achieved PR, 95 patients progressed to ESRD and 36 patients died. Prognosis and treatment response of patients with different histological types differ apparently. Renal outcome of patients with LN II and III was benign, while LN IV, V and VI was poor. Cyclophosphamide was effective in most patients. MMF and CNI could be used as salvage treatment. In multivariate analysis, BP, sCr, hypocomplementemia, severe proliferative lesion (LN IV or VI) and SLEDAI score were recognized as independent indicators of poor renal outcome. Infections, especially pulmonary fungus infection, thrombotic microangiopathy are the most common causes of death in LN patients.
Conclusions
Clinicopathological characteristics, treatment responses and long-term outcomes differ remarkably in LN patients with different gender and pathological subtypes. New indicators of poor renal outcome were identified. Infections and TTP were the most common causes of death in LN patients.
Similar content being viewed by others
References
Jakes RW, Bae SC, Louthrenoo W et al (2012) Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken) 64(2):159–168
Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288–291
Weening JJ, D’Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15(2):241–250
Wang YF, Xu YX, Tan Y et al (2012) Clinicopathological characteristics and outcomes of male lupus nephritis in China. Lupus 21(13):1472–1481
Hsu CY, Chiu WC, Yang TS et al (2011) Age- and gender-related long-term renal outcome in patients with lupus nephritis. Lupus 20(11):1135–1141
Resende AL, Titan SM, Barros RT et al (2011) Worse renal outcome of lupus nephritis in male patients: a case-control study. Lupus 20(6):561–567
Cavagna L, Caporali R, Esposito C et al (2007) Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. Scand J Rheumatol 36(1):74–76
Zhao MH, Liu N, Zhang YK et al (1998) Antineutrophil cytoplasmic autoantibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis. Nephrol Dial Transplant 13(11):2821–2824
Yokoyama H, Wada T, Hara A et al (2004) The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese. Kidney Int 66(6):2382–2388
Vozmediano C, Rivera F, Lopez-Gomez JM et al (2012) Risk factors for renal failure in patients with lupus nephritis: data from the spanish registry of glomerulonephritis. Nephron Extra 2(1):269–277
Okpechi IG, Ayodele OE, Jones ES et al (2012) Outcome of patients with membranous lupus nephritis in Cape Town South Africa. Nephrol Dial Transplant 27(9):3509–3515
Mercadal L, Montcel ST, Nochy D et al (2002) Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 17(10):1771–1778
Henderson LK, Masson P, Craig JC et al (2013) Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis 61(1):74–87
Rovin BH, Parikh SV, Hebert LA et al (2013) Lupus nephritis: induction therapy in severe lupus nephritis–should MMF be considered the drug of choice? Clin J Am Soc Nephrol 8(1):147–153
Faurschou M, Dreyer L, Kamper AL et al (2010) Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res (Hoboken) 62(6):873–880
Korbet SM, Lewis EJ, Schwartz MM et al (2000) Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 35(5):904–914
Riboldi P, Gerosa M, Moroni G et al (2005) Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? Autoimmunity 38(1):39–45
Yap DY, Tang CS, Ma MK et al (2012) Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant 27(8):3248–3254
Telles RW, Lanna CC, Souza FL et al (2013) Causes and predictors of death in Brazilian lupus patients. Rheumatol Int 33(2):467–473
Barber CE, Barnabe C (2012) Another consequence of severe lupus: invasive fungal disease. J Rheumatol 39(9):1772–1774
Vinicki JP, Pellet SC, Pappalardo C et al (2013) Invasive fungal infections in Argentine patients with systemic lupus erythematosus. Lupus 22(9):892–898
Jiang H, An X, Li Y et al (2014) Clinical features and prognostic factors of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a literature review of 105 cases from 1999 to 2011. Clin Rheumatol 33(3):419–427
Dhir V, Aggarwal A, Lawrence A et al (2012) Long-term outcome of lupus nephritis in Asian Indians. Arthritis Care Res (Hoboken) 64(5):713–720
Contreras G, Pardo V, Cely C et al (2005) Factors associated with poor outcomes in patients with lupus nephritis. Lupus 14(11):890–895
Moroni G, Quaglini S, Gallelli B et al (2013) Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years. Lupus 22(8):810–818
Acknowledgments
This work was partly supported by National Natural Science Foundation of China (Nos. 30800527 and 81270793). Our sincere thanks go to Professor Ye Tao, Zhangxue Hu, and all the staff of Nephrology Division for their help.
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yi Tang, XiaoYan Zhang and Ling Ji have contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Tang, Y., Zhang, X., Ji, L. et al. Clinicopathological and outcome analysis of adult lupus nephritis patients in China. Int Urol Nephrol 47, 513–520 (2015). https://doi.org/10.1007/s11255-014-0903-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0903-y